Celiac disease as a model of gut–brain autoimmunity: from gluten exposure to neuropsychiatric manifestations - Report - MDSpire

Celiac disease as a model of gut–brain autoimmunity: from gluten exposure to neuropsychiatric manifestations

  • By

  • Valentina Pucinischi

  • Martina Piersanti

  • Giovanni Di Nardo

  • Matteo Guarino

  • Umberto Volta

  • Roberto De Giorgio

  • Renata Auricchio

  • Alessandro Ferretti

  • Pasquale Parisi

  • Maurizio Mennini

  • May 14, 2026

  • 0 min

Share

Clinical Report: Celiac Disease and Neuropsychiatric Symptoms

Overview

Celiac disease (CeD) is associated with a range of neuropsychiatric symptoms, including depression and cognitive dysfunction. The pathophysiology involves autoimmune responses and neuroinflammation, with varying clinical outcomes based on dietary adherence.

Background

Celiac disease is a systemic immune-mediated disorder triggered by gluten in genetically predisposed individuals, leading to gastrointestinal and extraintestinal manifestations. The recognition of neuropsychiatric symptoms as significant components of CeD is crucial for comprehensive patient management. Understanding these associations can enhance early diagnosis and treatment strategies.

Data Highlights

No numerical data or trial data available in the source material.

Key Findings

  • Neurological manifestations of CeD include cerebellar ataxia, peripheral neuropathy, and cognitive dysfunction.
  • Psychiatric symptoms associated with CeD encompass depression, anxiety, and ADHD.
  • Autoimmune mechanisms, including anti-transglutaminase 6 antibodies, may play a role in neuropsychiatric symptoms.
  • Some patients experience persistent symptoms despite adherence to a gluten-free diet.
  • Pediatric patients typically show milder neurological involvement compared to adults.

Clinical Implications

Healthcare professionals should be vigilant for neuropsychiatric symptoms in patients with celiac disease, as these can significantly impact quality of life. Early identification and a multidisciplinary approach are essential for effective management and prevention of long-term neurological damage.

Conclusion

Neuropsychiatric manifestations are an important yet often overlooked aspect of celiac disease. Comprehensive management strategies should include dietary monitoring and psychological support to optimize patient outcomes.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. The New Gastroenterologist, 2025 -- B Cells in Peyer’s Patches Contribute to the Production of TG2 Autoantibodies in Celiac Disease
  3. Optometric Management, 2011 -- Reflections
  4. The New Gastroenterologist, 2025 -- Celiac Disease: Recent Advances in Diagnosis and Patient Monitoring
  5. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach
  6. Therapeutic Restoration of Systemic Multiomic Responses by Transglutaminase 2 inhibitor in Celiac Disease: A Gluten Challenge Approach | medRxiv
  7. CSF Markers of TG6 Autoimmunity in Gluten Ataxia - PubMed
  8. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach
  9. Therapeutic Restoration of Systemic Multiomic Responses by Transglutaminase 2 inhibitor in Celiac Disease: A Gluten Challenge Approach | medRxiv
  10. CSF Markers of TG6 Autoimmunity in Gluten Ataxia - PubMed

Original Source(s)

Related Content